NK

Nikil Karunakara Rai

Director Director DIN 06928050
DIN 06928050 First appointment Sep 2014 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Sep 2014
Shareholding value Locked Premium profile

About Nikil Karunakara Rai

Nikil Karunakara Rai has 11 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 06928050
Primary Designation Director
First Appointment 10 Sep 2014
Oldest Company Age 11 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Animus Pharmaceuticals Private Limited U24232KA2014PTC076314
Director 10 Sep 2014 2014 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Animus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nikil Karunakara Rai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nikil Karunakara Rai

Nikil Karunakara Rai has 11 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Nikil Karunakara Rai is associated with 0 companies as Director.

Nikil Karunakara Rai has expertise in General Business.

Nikil Karunakara Rai has 11 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available